Brief: Cosmos Health Reaffirms 2029 Guidance
03/09/2026 15:49
BRIEF-Cosmos Health Reaffirms 2029 Guidance Sept 3 (Reuters) - Cosmos Health Inc COSM.O:
COSMOS HEALTH: A COMPANY TRANSFORMED — 2026 YEAR-TO-DATE
COSMOS HEALTH - 2029 GUIDANCE REAFFIRMED: $200.60M REVENUE, $71.20M GROSS PROFIT, $31M NET INCOME, $44.20M ADJUSTED EBITDA
Source text: ID:nGNX3V2VVy
Further company coverage: COSM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cosmos Health
See all newsCosmos Health Q3 revenue rises to record high on contract manufacturing
Brief: Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar
Brief: Cosmos Health Reaffirms 2029 Guidance
Brief: Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal With Innova Healthcare
Brief: Cosmos Health Reports Q2 2026